anti-cancer – media

Zapping tumors in less than a second

Researchers at SLAC and Stanford are developing new accelerator-based technology that aims to speed up cancer radiation therapy by hundreds of times and make related medical devices more compact. The approach could reduce side effects in patients and possibly make radiation therapy more accessible around the world.
- Source: www.sciencedaily.com/releases/2018/11/181130175055.htm
- 586
- December 28, 2018
anti-cancer New-tech
Personalized Cancer Vaccine Looks Promising in Early Study

Researchers at the Perelman School of Medicine and the Abramson Cancer Center, at the University of Pennsylvania, developed the vaccine using dendritic cells (DCs) derived from each patient's own peripheral blood mononuclear cells. These dendritic cells were then exposed to the patient's tumor cells, activated with interferon gamma, and injected into the patient's lymph nodes.
- Source: Clinical Advisor
- 657
- May 15, 2018
anti-cancer cancer Researches
Aspyrian Therapeutics Inc. announces successful advances in RM-1929 clinical development

Aspyrian Therapeutics Inc. announces successful advances in RM-1929 clinical development in recurrent Head and Neck Cancer, including Fast Track designation granted by the FDA, initiation of clinical studies in Japan, and plans to start pivotal studies, which will incorporate the evaluation of anti-cancer immune responses, in early 2018.
- Source: Prnewswire
- 758
- January 19, 2018
anti-cancer immune New Approvals RM-1929

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.